Unlock Exclusive Discounts & Flash Sales! Click Here to Join the Deals on Every Wednesday!
For the final target formulation, the amount of inorganic ions (such as sodium, potassium, magnesium, calcium, chlorine, and phosphate) in oligonucleotide drugs for intrathecal administration needs to be controlled. Measurements of these ions during process development are required to ensure that solution composition does not change during purification or drug preparation and to ensure that the ultimate drug goal is achieved.